Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency (HIDS-MKD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by Michigan Technological University.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Kenneth Michael Gibson, Michigan Technological University
ClinicalTrials.gov Identifier:
NCT01568736
First received: March 29, 2012
Last updated: March 30, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)